An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor

The Oncologist
Erkut BorazanciGayle Jameson

Abstract

Molecular analysis has revealed four subtypes of pancreatic ductal adenocarcinoma (PDAC). One subtype identified for the presence of DNA damage repair deficiency can be targeted therapeutically with the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib. We performed a single institution retrospective analysis of treatment response in patients with PDAC treated with olaparib who have DNA damage repair deficiency mutations. Patients with germline or somatic mutations involving the DNA repair pathway were identified and treated with olaparib. The primary objective was to examine the objective response rate (ORR). The secondary objectives were assessing tolerability, overall survival, and change in cancer antigen 19-9. Quantitative texture analysis (QTA) was evaluated from CT scans to explore imaging biomarkers. Thirteen individuals with metastatic PDAC were treated with Olaparib. The ORR to Olaparib was 23%. Median overall survival (OS) was 16.47 months. Four of seven patients with BRCA mutations had an effect on RAD51 binding, with a median OS of 24.60 months. Exploratory analysis of index lesions using QTA revealed correlations between lesion texture and OS (hepatic lesion tumor texture correlation coefficient [CC], 0.683, ...Continue Reading

References

Jun 26, 2009·The New England Journal of Medicine·Peter C FongJohann S de Bono
Aug 24, 2012·AJR. American Journal of Roentgenology·Shota YamamotoMichael D Kuo
Nov 3, 2012·Cancer Research·Junko MuraiYves Pommier
Sep 26, 2013·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Kenneth A MilesMichael P Hayball
Nov 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bella KaufmanSusan M Domchek
Feb 27, 2015·Nature·Nicola WaddellSean M Grimmond
Jun 3, 2015·Cancer Treatment Reviews·Panagiota EconomopoulouGeorge Pentheroudakis
Oct 29, 2015·The New England Journal of Medicine·Joaquin MateoJohann S de Bono
May 3, 2016·Nature·Serena Nik-ZainalMichael R Stratton
Jan 4, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Mary B DalySusan Darlow
Feb 9, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E J LimkinC Ferté
Apr 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erkut BorazanciDaniel D Von Hoff
Jun 6, 2017·The New England Journal of Medicine·Mark RobsonPierfranco Conte
Jul 26, 2017·BMC Cancer·Kirsi M MäättäJohanna Schleutker
Nov 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·S Intidhar Labidi-GalyIsabelle Ray-Coquard
Dec 11, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maeve A LoweryEileen M O'Reilly
Nov 16, 2018·Insights Into Imaging·Emanuele NeriRomano Danesi
Jun 4, 2019·The New England Journal of Medicine·Talia GolanHedy L Kindler

❮ Previous
Next ❯

Citations

May 1, 2021·American Society of Clinical Oncology Educational Book·Michael S Lee, Shubham Pant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.